Literature DB >> 21448756

The Alabama Drug Discovery Alliance: a collaborative partnership to facilitate academic drug discovery.

Maaike Everts1, W Blaine Knight, David R Harris, John A Secrist, Richard J Whitley.   

Abstract

The Alabama Drug Discovery Alliance is a collaboration between the University of Alabama at Birmingham and Southern Research Institute that aims to support the discovery and development of therapeutic molecules that address an unmet medical need. The alliance builds on the expertise present at both institutions and has the dedicated commitment of their respective technology transfer and intellectual property offices to guide any commercial opportunities that may arise from the supported efforts. Although most projects involve high throughput screening, projects at any stage in the drug discovery and development pathway are eligible for support. Irrespective of the target and stage of any project, well-functioning interdisciplinary teams are crucial to a project's progress. These teams consist of investigators with a wide variety of expertise from both institutions to contribute to the program's success.

Entities:  

Mesh:

Year:  2011        PMID: 21448756      PMCID: PMC3161513          DOI: 10.1007/s11095-011-0432-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

Review 1.  Prospects for productivity.

Authors:  Bruce Booth; Rodney Zemmel
Journal:  Nat Rev Drug Discov       Date:  2004-05       Impact factor: 84.694

2.  Driving drug discovery: the fundamental role of academic labs.

Authors:  B Michael Silber
Journal:  Sci Transl Med       Date:  2010-05-05       Impact factor: 17.956

Review 3.  Small-molecule screening: it takes a village...

Authors:  Eva J Gordon
Journal:  ACS Chem Biol       Date:  2007-01-23       Impact factor: 5.100

4.  Drug discovery in jeopardy.

Authors:  Pedro Cuatrecasas
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

Review 5.  The advancement of translational medicine-from regional challenges to global solutions.

Authors:  Salvatore Albani; Berent Prakken
Journal:  Nat Med       Date:  2009-09       Impact factor: 53.440

Review 6.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

7.  Patently naive.

Authors: 
Journal:  Nat Med       Date:  2009-11       Impact factor: 53.440

8.  The role of public-sector research in the discovery of drugs and vaccines.

Authors:  Ashley J Stevens; Jonathan J Jensen; Katrine Wyller; Patrick C Kilgore; Sabarni Chatterjee; Mark L Rohrbaugh
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

9.  In the land of the monolingual.

Authors: 
Journal:  Nat Med       Date:  2009-09       Impact factor: 53.440

Review 10.  Integration of small-molecule discovery in academic biomedical research.

Authors:  Michael Ohlmeyer; Ming-Ming Zhou
Journal:  Mt Sinai J Med       Date:  2010 Jul-Aug
View more
  2 in total

1.  Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective.

Authors:  Maaike Everts; Mark J Suto; George R Painter; Richard J Whitley
Journal:  Future Virol       Date:  2016-02-29       Impact factor: 1.831

2.  Highlights of the 30th International Conference on Antiviral Research.

Authors:  Graciela Andrei; Kara Carter; Zlatko Janeba; Aruna Sampath; Luis M Schang; E Bart Tarbet; R Anthony Vere Hodge; Mike Bray; José A Esté
Journal:  Antiviral Res       Date:  2017-08-01       Impact factor: 5.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.